The Relative Cerebral Blood Volume (rCBV) < 42% Is Independently Associated with Collateral Status in Anterior Circulation Large Vessel Occlusion
<b>Background:</b> The pretreatment CT perfusion (CTP) marker the relative cerebral blood volume (rCBV) < 42% lesion volume has recently been shown to predict 90-day functional outcomes; however, studies assessing correlations of the rCBV < 42% lesion volume with other outcomes rem...
Main Authors: | Dhairya A. Lakhani, Aneri B. Balar, Manisha Koneru, Sijin Wen, Burak Berksu Ozkara, Hanzhang Lu, Richard Wang, Meisam Hoseinyazdi, Janet Mei, Risheng Xu, Mehreen Nabi, Ishan Mazumdar, Andrew Cho, Kevin Chen, Sadra Sepehri, Nathan Hyson, Victor Urrutia, Licia Luna, Argye E. Hillis, Jeremy J. Heit, Greg W. Albers, Ansaar T. Rai, Adam A. Dmytriw, Tobias Faizy, Max Wintermark, Kambiz Nael, Vivek S. Yedavalli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/13/6/1588 |
Similar Items
-
Unlocking Bevacizumab’s Potential: rCBV<sub>max</sub> as a Predictive Biomarker for Enhanced Survival in Glioblastoma IDH-Wildtype Patients
by: María del Mar Álvarez-Torres, et al.
Published: (2023-12-01) -
Dataset of voxelwise correlated signal values of ADC, rCBV and FAP-specific PET of 13 Glioblastoma patients
by: Manuel Röhrich, et al.
Published: (2020-08-01) -
The Compensation Index Is Better Associated with DSA ASITN Collateral Score Compared to the Cerebral Blood Volume Index and Hypoperfusion Intensity Ratio
by: Dhairya A. Lakhani, et al.
Published: (2023-11-01) -
Early post-bevacizumab change in rCBV from DSC-MRI identifies pseudoresponse in recurrent glioblastoma: Results from ACRIN 6677/RTOG 0625
by: Jerrold L. Boxerman, et al.
Published: (2023-01-01) -
Practical guidance to identify and troubleshoot suboptimal DSC-MRI results
by: Melissa A. Prah, et al.
Published: (2024-02-01)